AI intervention in Epilepsy Diagnosis and Treatment

By Sumona Bose

February 15, 2024

Introduction

Epilepsy, a neurological disorder characterised by recurrent seizures, affects millions of people worldwide. The ability to accurately detect and predict seizures is crucial for effective management and treatment of this condition. In recent years, artificial intelligence (AI) and machine learning have emerged as powerful tools in the field of epilepsy research, offering new insights and possibilities for improving patient outcomes. AI intervention in epilepsy diagnosis and treatment remain a sought after matter of investigation.

Examining Epileptic Brain States

Epileptic brain dynamics can be divided into four states: inter-ictal(period between seizures, i.e., a normal state of patients), pre-ictal (period immediately before the seizure onset), ictal (period during seizure), and post-ictal (period immediately after the seizure). Understanding the characteristics of each state and the transitions between them is essential for unravelling the mechanisms underlying epilepsy and developing targeted interventions. Traditional studies have focused on seizure detection and prediction, aiming to identify the onset of seizures and forecast their occurrence in advance.

Many recent studies have focused on implementing the computational predictive models to localize SOZs or judge epileptic brain states, such as pre-ictal and ictal onset, by employing traditional machine learning algorithms or deep learning algorithms based on scalp EEG and/or iEEG data recorded from epilepsy patients. Compared to the traditional machine learning approach, which consists of two step processes of manually extracting the features of the data and training the machine by applying the features as inputs, deep learning approach automatically figures out the discriminative features from data and learns them. SOZ, seizure onset zones; EEG, electroencephalogram; iEEG, intracranial EEG.

An external file that holds a picture, illustration, etc.Object name is jer-20003f2.jpg
Figure 1: Machine learning-based computational approach.

AI in Seizure Detection

Numerous studies have demonstrated the effectiveness of computational models in seizure detection. These models, trained using machine learning algorithms, can analyse data from scalp electroencephalography (EEG) or intracranial EEG recordings to identify seizure patterns. For instance, Emami and colleagues developed a convolutional neural network (CNN)-based model that automatically learned the characteristics of seizure and non-seizure states. The model achieved an average positive rate of 74% for seizure onset detection when the entire EEG time series was input sequentially by one second. This breakthrough paves the way for on-demand stimulation therapies or acute drug treatments, providing timely interventions for patients.

AI in Seizure Prediction

Predicting seizures before their onset is another critical aspect of epilepsy management. Computational models trained on time and/or frequency domain features observed in the pre-ictal state have shown promising results in predicting seizures several minutes before they occur. These models, employing supervised learning methods and various algorithms such as support vector machines (SVM) and deep learning techniques like recurrent neural networks (RNN), have achieved sensitivities of 80-90%. Importantly, recent studies have focused on developing patient-specific models based on individual data, recognizing the unique signal patterns of each patient. This personalised approach holds great potential for clinical applications, enabling tailored treatment plans and interventions.

In conclusion, the integration of AI and machine learning in epilepsy research has shown promise in the field by enabling accurate seizure detection and prediction. These computational models have the potential to improve patient outcomes by providing timely interventions and personalised treatment plans. As technology continues to advance, AI will play an increasingly vital role in transforming epilepsy diagnosis and treatment.

Reference url

Recent Posts

AI Drug Safety Surveillance
           

Created and Validated by FDA: AI Drug Safety Surveillance Tool

🚀 Discover how the AI-driven LabelComp tool is transforming drug safety surveillance! By automating the identification of adverse events in drug labelling, LabelComp enhances accuracy and efficiency, supporting regulatory decision-making and public health. 🌐💊
#SyenzaNews #AIinHealthcare #DrugSafety #PharmaInnovation #RegulatoryScience

School-based health centres
                      

The Role of School-Based Health Centres in Advancing Health Equity

🌟 School-based health centres (SBHCs) are improving healthcare for underserved youth across the US! These centres provide vital services, from preventive care to chronic disease management, right where students need them most – in schools. 📚🏥

SBHCs improve academic performance, reduce absenteeism, and enhance overall student well-being. Let’s support these essential centres and ensure every child has access to quality healthcare. 🌟

#SyenzaNews #SBHC #ChronicDiseaseManagement #HealthEquity #PreventiveCare

ABA guidelines for Autism
                

Enhancing Care in Abu Dhabi: The New ABA Guidelines for Autism

🌟 Exciting developments in Abu Dhabi! The Department of Health has introduced new ABA guidelines for Autism Spectrum Disorder, aiming to improve care for People of Determination. This initiative focuses on standardising care, enhancing accessibility, and fostering collaboration between healthcare and education professionals.
Learn more about how these guidelines can make a difference in the lives of individuals with ASD.
#SyenzaNews #HealthcareInnovation #AutismCare #InclusiveHealth #ABAGuidelines #AbuDhabiHealth

When you collaborate with VSH Foundation, it's like unlocking a new dimension in healthcare innovation.

Our research synergizes with your vision, combining expertise in health economics, policy analysis, advanced analytics, and AI applications in healthcare. You’ll witness the fusion of cutting-edge methodologies and real- world impact, as we work together to transform healthcare systems and improve patient outcomes globally.

CORRESPONDENCE ADDRESS

PO Box 8547, #95478, Boston, MA 02114, USA

© 2024 Value Science Health Foundation. All rights reserved.
Made with by Frogiez